{"2409.18924": {"publish_time": "2024-09-27", "title": "AIPatient: Simulating Patients with EHRs and LLM Powered Agentic Workflow", "paper_summary": "Simulated patient systems play a crucial role in modern medical education and\nresearch, providing safe, integrative learning environments and enabling\nclinical decision-making simulations. Large Language Models (LLM) could advance\nsimulated patient systems by replicating medical conditions and patient-doctor\ninteractions with high fidelity and low cost. However, ensuring the\neffectiveness and trustworthiness of these systems remains a challenge, as they\nrequire a large, diverse, and precise patient knowledgebase, along with a\nrobust and stable knowledge diffusion to users. Here, we developed AIPatient,\nan advanced simulated patient system with AIPatient Knowledge Graph (AIPatient\nKG) as the input and the Reasoning Retrieval-Augmented Generation (Reasoning\nRAG) agentic workflow as the generation backbone. AIPatient KG samples data\nfrom Electronic Health Records (EHRs) in the Medical Information Mart for\nIntensive Care (MIMIC)-III database, producing a clinically diverse and\nrelevant cohort of 1,495 patients with high knowledgebase validity (F1 0.89).\nReasoning RAG leverages six LLM powered agents spanning tasks including\nretrieval, KG query generation, abstraction, checker, rewrite, and\nsummarization. This agentic framework reaches an overall accuracy of 94.15% in\nEHR-based medical Question Answering (QA), outperforming benchmarks that use\neither no agent or only partial agent integration. Our system also presents\nhigh readability (median Flesch Reading Ease 77.23; median Flesch Kincaid Grade\n5.6), robustness (ANOVA F-value 0.6126, p<0.1), and stability (ANOVA F-value\n0.782, p<0.1). The promising performance of the AIPatient system highlights its\npotential to support a wide range of applications, including medical education,\nmodel evaluation, and system integration.", "paper_summary_zh": "<paragraph>\u6a21\u64ec\u75c5\u4eba\u7cfb\u7d71\u5728\u73fe\u4ee3\u91ab\u5b78\u6559\u80b2\u548c\u7814\u7a76\u4e2d\u626e\u6f14\u8457\u81f3\u95dc\u91cd\u8981\u7684\u89d2\u8272\uff0c\u63d0\u4f9b\u5b89\u5168\u3001\u6574\u5408\u7684\u5b78\u7fd2\u74b0\u5883\uff0c\u4e26\u652f\u63f4\u81e8\u5e8a\u6c7a\u7b56\u6a21\u64ec\u3002\u5927\u578b\u8a9e\u8a00\u6a21\u578b (LLM) \u80fd\u5920\u8907\u88fd\u91ab\u7642\u72c0\u6cc1\u548c\u91ab\u75c5\u4e92\u52d5\uff0c\u9032\u800c\u4ee5\u9ad8\u4fdd\u771f\u5ea6\u548c\u4f4e\u6210\u672c\u63d0\u5347\u6a21\u64ec\u75c5\u4eba\u7cfb\u7d71\u3002\u7136\u800c\uff0c\u78ba\u4fdd\u9019\u4e9b\u7cfb\u7d71\u7684\u6709\u6548\u6027\u548c\u53ef\u4fe1\u5ea6\u4ecd\u7136\u662f\u4e00\u9805\u6311\u6230\uff0c\u56e0\u70ba\u5b83\u5011\u9700\u8981\u4e00\u500b\u9f90\u5927\u3001\u591a\u5143\u4e14\u7cbe\u78ba\u7684\u75c5\u4eba\u77e5\u8b58\u5eab\uff0c\u4ee5\u53ca\u4e00\u7a2e\u5f37\u5065\u4e14\u7a69\u5b9a\u7684\u77e5\u8b58\u50b3\u64ad\u65b9\u5f0f\u3002\u5728\u6b64\uff0c\u6211\u5011\u958b\u767c\u4e86 AIPatient\uff0c\u4e00\u500b\u9032\u968e\u7684\u6a21\u64ec\u75c5\u4eba\u7cfb\u7d71\uff0c\u5176\u4ee5 AIPatient \u77e5\u8b58\u5716\u8b5c (AIPatient KG) \u4f5c\u70ba\u8f38\u5165\uff0c\u4e26\u4ee5\u63a8\u7406\u6aa2\u7d22\u589e\u5f37\u751f\u6210 (Reasoning RAG) \u4ee3\u7406\u5de5\u4f5c\u6d41\u7a0b\u4f5c\u70ba\u751f\u6210\u4e3b\u5e79\u3002AIPatient KG \u5f9e\u5bc6\u96c6\u7167\u8b77\u91ab\u5b78\u8cc7\u8a0a\u5e02\u96c6 (MIMIC)-III \u8cc7\u6599\u5eab\u4e2d\u7684\u96fb\u5b50\u5065\u5eb7\u7d00\u9304 (EHR) \u4e2d\u62bd\u53d6\u8cc7\u6599\uff0c\u7522\u751f\u4e00\u500b\u81e8\u5e8a\u591a\u5143\u4e14\u76f8\u95dc\u7684 1,495 \u4f4d\u75c5\u60a3\u7fa4\u7d44\uff0c\u4e14\u5177\u6709\u9ad8\u5ea6\u7684\u77e5\u8b58\u5eab\u6709\u6548\u6027 (F1 0.89)\u3002Reasoning RAG \u904b\u7528\u516d\u500b LLM \u9a45\u52d5\u7684\u4ee3\u7406\uff0c\u6db5\u84cb\u6aa2\u7d22\u3001KG \u67e5\u8a62\u751f\u6210\u3001\u62bd\u8c61\u5316\u3001\u6aa2\u67e5\u5668\u3001\u91cd\u5beb\u548c\u6458\u8981\u7b49\u4efb\u52d9\u3002\u6b64\u4ee3\u7406\u67b6\u69cb\u5728\u57fa\u65bc EHR \u7684\u91ab\u7642\u554f\u7b54 (QA) \u4e2d\u9054\u5230 94.15% \u7684\u6574\u9ad4\u6e96\u78ba\u5ea6\uff0c\u512a\u65bc\u672a\u4f7f\u7528\u4ee3\u7406\u6216\u50c5\u90e8\u5206\u6574\u5408\u4ee3\u7406\u7684\u57fa\u6e96\u3002\u6211\u5011\u7684\u7cfb\u7d71\u9084\u5177\u5099\u9ad8\u5ea6\u53ef\u8b80\u6027 (\u4e2d\u4f4d\u6578 Flesch \u95b1\u8b80\u7c21\u6613\u5ea6 77.23\uff1b\u4e2d\u4f4d\u6578 Flesch Kincaid \u7b49\u7d1a 5.6)\u3001\u5f37\u5065\u6027 (ANOVA F \u503c 0.6126\uff0cp<0.1) \u548c\u7a69\u5b9a\u6027 (ANOVA F \u503c 0.782\uff0cp<0.1)\u3002AIPatient \u7cfb\u7d71\u4ee4\u4eba\u6eff\u610f\u7684\u6548\u80fd\u7a81\u986f\u4e86\u5176\u652f\u63f4\u5ee3\u6cdb\u61c9\u7528\u7a0b\u5f0f\u7684\u6f5b\u529b\uff0c\u5305\u62ec\u91ab\u5b78\u6559\u80b2\u3001\u6a21\u578b\u8a55\u4f30\u548c\u7cfb\u7d71\u6574\u5408\u3002</paragraph>", "author": "Huizi Yu et.al.", "authors": "Huizi Yu, Jiayan Zhou, Lingyao Li, Shan Chen, Jack Gallifant, Anye Shi, Xiang Li, Wenyue Hua, Mingyu Jin, Guang Chen, Yang Zhou, Zhao Li, Trisha Gupte, Ming-Li Chen, Zahra Azizi, Yongfeng Zhang, Themistocles L. Assimes, Xin Ma, Danielle S. Bitterman, Lin Lu, Lizhou Fan", "id": "2409.18924v1", "paper_url": "http://arxiv.org/abs/2409.18924v1", "repo": "null"}}